Targeted Gene Sequencing to Discover Predictive Markers Associated With Chemotherapy Outcome in Patients With Recurrence of Pancreatic Adenocarcinoma After Surgical Resection
B
Bert O'Neil, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to compare patterns of gene mutation in patients with good response vs. poor response to chemotherapy as determined by overall survival after diagnosis of metastatic disease.
Description
The purpose of this study is to compare patterns of gene mutation in patients with good response vs. poor response to chemotherapy as determined by overall survival after diagnosis of metastatic disease.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
pancreatic cancer
-
Age: - 100 Years
-
Gender: All
Updated on
23 Apr 2024.
Study ID: 1505655515
